Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing Cancer Metastasis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25084283 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Han-En Tsai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Academia Sinica, Taipei 115, Taiwan. Hauptthemen laut MEDLINE: Sialyltransferases, Cell Movement. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academia Sinica, Ministry of Science and Technology, TAIWAN, Kaohsiung Armed Forces General Hospital, TAIWAN.
Abstract (Originalsprache)
Sialyltransferase-catalyzed membrane protein and lipid glycosylation plays a vital role as one of the most abundant post-translational modifications and diversification reactions in eukaryotes. However, aberrant sialylation has been associated with cancer malignancy and metastasis. Sialyltransferases thus represent emerging targets for the development of small molecule cancer drugs. Herein, we report the inhibitory effects of a recently discovered lithocholic acid derivative FCW393 on sialyltransferase catalytic activity, integrin sialyation, cancer-associated signal transduction, MDA-MB-231 and B16F10 cell migration and invasion, and in in vivo studies, on tumor growth, metastasis, and angiogenesis. FCW393 showed effective and selective inhibition of the sialyltransferases ST6GAL1 (IC50 = 7.8 μM) and ST3GAL3 (IC50 = 9.45 μM) relative to ST3GAL1 (IC50 > 400 μM) and ST8SIA4 (IC50 > 100 μM). FCW393 reduced integrin sialylation in breast cancer and melanoma cells dose-dependently and downregulated proteins associated with the integrin-regulated FAK/paxillin and GEF/Rho/ROCK pathways, and with the VEGF-regulated Akt/NFκB/HIF-1α pathway. FCW393 inhibited cell migration (IC50 = 2.6 μM) and invasion in in vitro experiments, and in in vivo studies of tumor-bearing mice, FCW393 reduced tumor size, angiogenesis, and metastatic potential. Based on its demonstrated selectivity, cell permeability, relatively low cytotoxicity (IC50 = 55 μM), and high efficacy, FCW393 shows promising potential as a small molecule experimental tool compound and a lead for further development of a novel cancer therapeutic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemistry, Academia Sinica, Taipei 115, Taiwan.
- Biomedical Translation Research Center, Academia Sinica, National Biotechnology Research Park, Taipei 115, Taiwan.
- Department of Chemistry, National Central University, Taoyuan 320, Taiwan.
- Department of Chemistry, National Taiwan Normal University, Taipei 106, Taiwan.
- Department of Applied Chemistry, National Yang Ming Chiao Tung University, Hsinchu 300, Taiwan.
- Sustainable Chemical Science and Technology, Taiwan International Graduate Program, National Yang Ming Chiao Tung University and Academia Sinica, Taipei 115, Taiwan.
ORCID-Profile: Ser John Lynon P Perez, Wen-Shan Li
Förderung
- Academia Sinica
- Ministry of Science and Technology, TAIWAN
- Kaohsiung Armed Forces General Hospital, TAIWAN
- Ministry of Science and Technology
- Kaohsiung Armed Forces General Hospital
Zitieren
APA
Tsai, H. E., Chen, C. L., Chang, T. T., Fu, C. W., Chen, W. C., Perez, S. J. L. P., Hsiao, P. W., Tai, M. H., & Li, W. S. (2024). Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing Cancer Metastasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084283
Vancouver
Tsai HE, Chen CL, Chang TT, Fu CW, Chen WC, Perez SJLP, et al. Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing Cancer Metastasis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084283
BibTeX
@article{Tsai2024,
author = {Tsai, Han-En and Chen, Chia-Ling and Chang, Tzu-Ting and Fu, Chih-Wei and Chen, Wei-Chia and Perez, Ser John Lynon P and Hsiao, Pei-Wen and Tai, Ming-Hong and Li, Wen-Shan},
title = {Development of a Novel, Potent, and Selective Sialyltransferase Inhibitor for Suppressing Cancer Metastasis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25084283}
}
EUVIMED